Identification of proteins indicating radiation-induced Hepatic Toxicity in cirrhotic rats

Journal of Radiation Research

Volumn 51, Issue 6, 2010, Pages 643-650

  Chung, Sook In ^a   Seong, Jinsil ^a   Park, Young Nyun ^a   Kim, Won Woo ^a   Oh, Hae Jin ^a   Han, Kwang Hyub ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Hepatic injury; Liver cirrhosis; Proteomics; Radiation

Indexed keywords

BODY FLUIDS; CELL DEATH; ELECTROPHORESIS; MASS SPECTROMETRY; MOLECULAR BIOLOGY; POTABLE WATER; PROTEINS; RADIOTHERAPY; RATS; TISSUE; TOXICITY;

HEPATIC FIBROSIS; HEPATIC INJURY; HEPATOCELLULAR CARCINOMA; IDENTIFICATION OF PROTEINS; LIVER CIRRHOSIS; LIVER TISSUE; RADIATION-INDUCED; SINGLE-DOSE; THIOACETAMIDE; WISTAR RAT;

RADIATION;

RATTUS; RATTUS NORVEGICUS;

EID: 78649773318     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.09114     Document Type: Article

References (36)

1. Blum HE (2005) Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol 11: 7391-7400.
2. Davis GL, et al (2008) Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ Med Cent) 21: 266-280.
3. Liang SX, et al (2006) Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerancetolerance. Int J Radiat Oncol Biol Phys 65: 426-434.
4. Park HC, et al (2002) Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 54: 150-155.
5. Seong J, et al (2003) Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients. Hepatol Res 27: 30-35.
6. Ingold JA, et al (1965) Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med 93: 200-208.
7. Seong J, et al (2003) Lethal hepatic injury by combined treatment of radiation plus chemotherapy in rats with thioacetamide-induced liver cirrhosis. Int J Radiat Oncol Biol Phys 57: 282-288.
8. Castells A, et al (1993) Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 18: 1121-1126.
9. Tanaka K, et al (1998) The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 82: 78-85.
10. An JH, et al (2006) Protein expression profiles in a rat cirrhotic model induced by thioacetamide. Korean J Hepatol 12: 93-102.
11. Seong J, et al (2000) Early alteration in TGF-β mRNA expression in irradiated rat liver. Int J Radiat Oncol Biol Phys 46: 639-643.
12. Lin RX, et al (2009) Proteomic analysis of ionizing radiation-induced proteins at the subcellular level. J Proteome Res 8: 390-399.
13. An JH, Kim J and Seong J (2004) Redox signaling by ionizing radiation in mouse liver. Ann N Y Acad Sci 1030: 86-94.
14. An JH and Seong J (2006) Proteomics analysis of apoptosis-regulating proteins in tissues with different radiosensitivity. J Radiat Res 47: 147-155.
15. Park EC, et al (2006) Effect of ionizing radiation on rat tissue: proteomic and biochemical analysis. Prep Biochem Biotechnol 36: 19-35.
16. Iozzo RV (2001) Haparanase sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108: 165-167.
17. Ilan N, Elkin M and Vlodavsky I (2006) Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 38: 2018-2039.
18. Escobar Galvis ML, et al (2007) Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparin sulfate. Nat Chem Biol 3: 773-338.
19. Zetser A, et al (2004) Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 117: 2249-2258.
20. McKenzie EA (2007) Heparanase: a target for drug discovery in cancer and inflammation. Br J Pharmacol 151: 1-14.
21. Nadav L, et al (2002) Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts. J Cell Sci 115: 2179-2187.
22. Parish CR, Freeman C and Hulett MD (2001) Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 1471: M99-M108.
23. Vlodavsky I, et al (1992) Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 12: 112-127.
24. Vlodavsky I, et al (2006) The impact of Heparanase and Heparin on cancer metastasis and angiogenesis. Pathophysiol Haemost Thromb 35: 116-127.
25. Hulett MD, et al (1999) Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 5: 803-809.
26. Elkin M, et al (2001) Heparanase as mediator of angiogenesis: mode of action. FASEB J 15: 1661-1663.
27. Zhang Y, et al (2007) Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma. Biochem Biophys Res Commun 358: 124-129.
28. Cheng JC, et al (2006) Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kB signal transduction pathway. Oncogene 25: 7009-7018.
29. Liang S-X, et al (2005) Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma. Cancer 103: 2181-2188.
30. Cheng JC, et al (2001) Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization. Int J Cancer 96: 243-252.
31. Inoue H, et al (2006) Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats. Int J Mol Med 17: 857-864.
32. Huh CG, et al (2004) Hepatocyte growth factor/c-MET signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA 101: 4477-4482.
33. Patijn GA, et al (1998) Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology 28: 707-716.
34. Okano J, Shiota G and Kawasaki H (1999) Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver diseases: an immunohistochemical study. Liver 19: 151-159.
35. Borowiak M, et al (2004) Met provides essential signals for liver regeneration. Proc Natl Acad Sci USA 101: 10608-10613.
36. Corpechot C, et al (2002) Hepatocyte growth factor and c-MET inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis. Am J Pathol 160: 613-620.